Taiyen Biotech
Taiyen Biotech Co., Ltd., commonly referred to as Taiyen Biotech, is a leading player in the biotechnology industry, headquartered in Taiwan (TW). Established in 2000, the company has made significant strides in the development of innovative health products, focusing on dietary supplements and functional foods that cater to a growing health-conscious market. With a strong presence in Asia and expanding operations globally, Taiyen Biotech is renowned for its unique formulations that combine traditional wisdom with modern science. Their core offerings include probiotics, herbal extracts, and nutritional supplements, all designed to enhance well-being and support a healthy lifestyle. Recognised for its commitment to quality and research, Taiyen Biotech has achieved notable milestones, positioning itself as a trusted name in the health and wellness sector. The company continues to lead with cutting-edge solutions that meet the evolving needs of consumers worldwide.
DitchCarbon Score
How does Taiyen Biotech's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Taiyen Biotech's score of 22 is higher than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Taiyen Biotech's reported carbon emissions
In 2023, Taiyen Biotech reported total carbon emissions of approximately 25,456,000 kg CO2e, comprising about 24,563,000 kg CO2e from Scope 1 and about 893,000 kg CO2e from Scope 2 emissions. This marks a slight increase from 2022, where emissions were about 25,321,000 kg CO2e, with Scope 1 emissions at approximately 24,318,000 kg CO2e and Scope 2 at about 1,003,000 kg CO2e. Over the years, Taiyen Biotech's emissions have shown fluctuations. In 2015, the company emitted about 26,732,410 kg CO2e (Scope 1), 614,460 kg CO2e (Scope 2), and 24,769,940 kg CO2e (Scope 3). By 2016, emissions decreased slightly to approximately 25,606,950 kg CO2e (Scope 1) and 735,820 kg CO2e (Scope 2), while Scope 3 emissions also saw a reduction to about 23,565,390 kg CO2e. In 2017, emissions rose again to about 27,029,330 kg CO2e (Scope 1) and 637,790 kg CO2e (Scope 2). Despite these emissions figures, Taiyen Biotech has not publicly disclosed specific reduction targets or initiatives as part of their climate commitments. The absence of documented reduction targets suggests a need for further transparency regarding their long-term climate strategy. The company operates within an industry context that increasingly prioritises sustainability and carbon footprint reduction, highlighting the importance of establishing clear climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Get Started| 2015 | 2016 | 2017 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 26,732,410 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 614,460 | 000,000 | 000,000 | 0,000,000 | 000,000 |
| Scope 3 | 24,769,940 | 00,000,000 | 00,000,000 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Taiyen Biotech is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
